Taurx To Present Two-Year Data From Phase III Trial Of HMTM

Taurx To Present Two-Year Data From Phase III Trial Of HMTM In Alzheimer's Disease At The AD/PDTM 2024 Conference In Marc...

Taurx To Present Two-Year Data From Phase III Trial Of HMTM In Alzheimer's Disease At The AD/PDTM 2024 Conference In Marc...

menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Singapore , Lisbon , Lisboa , Portugal , United Kingdom , Serge Gauthier , Claude Wischik , Henrik Zetterberg , Alistair Burns , David Watson , Taurx Pharmaceuticals Ltd , Diseases Conference , Executive Chairman , Professor Henrik Zetterberg , Professor Alistair Burns , Professor Claude Wischik , Professor Wischik ,